Acute asthma exacerbation in adults

When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Última revisão das evidências: 16 Sep 2026
Última atualização do tópico: 30 Sep 2026
30 Sep 2026

GINA develops updated assessment and treatment recommendations with new flowcharts for acute asthma exacerbation

A major initiative in the 2026 Global Initiative for Asthma (GINA) Strategy report has been the development of new flowcharts for the assessment, treatment, and follow-up of patients who present with an exacerbation or acute asthma. These focus treatment pathways around mild, moderate, severe, and life-threatening exacerbations when previously the approach for mild/moderate has been the same.

The new treatment flowcharts also give separate guidance for acute care and primary care settings.

There are a few important changes to highlight in this 2026 update:

  • Anaphylaxis and asthma: GINA now recommend that if anaphylaxis is suspected that epinephrine (adrenaline) should be given first before asthma treatment

  • Inhaled corticosteroid (ICS)-formoterol has been added as an option for mild exacerbations as an alternative to inhaled high-dose SABA

  • Oxygen saturation thresholds and targets: these have been revised, with supplemental oxygen only recommended when saturations fall below 92%

  • Discharge planning - even a single exacerbation is a potential “red flag” that the patient needs review of their asthma treatment, and clear guidance is given on follow up needed after an acute episode

Ver Tratamento: algoritmo de tratamento

Fonte original da atualização

Resumo

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • cough
  • wheezing
  • shortness of breath
  • chest tightness
  • sleep disturbance
  • accessory muscle use
  • tachypnea
  • tachycardia
  • progressive decrease in lung function
  • inability to speak
  • silent chest
Todos los datos

Otros factores de diagnóstico

  • exercise limitation
  • altered consciousness
  • stridor
  • cyanosis
Todos los datos

Factores de riesgo

  • respiratory viral infection
  • uncontrolled asthma symptoms
  • high use of short-acting beta-2 agonists
  • inconsistent use of inhaled corticosteroids (ICS)
  • incorrect inhaler technique
  • low forced expiratory volume in 1 second (FEV₁)
  • high bronchodilator responsiveness
  • current smoker (including e-cigarettes/vapes) or exposure to secondhand cigarette smoke
  • exposure to allergens (including history of seasonal allergic rhinitis)
  • air pollution
  • poor indoor air quality
  • obesity
  • chronic rhinosinusitis
  • gastroesophageal reflux disease
  • confirmed food allergy
  • history of asthma
  • history of hospitalization for asthma exacerbations
  • one or more severe exacerbations in the last 12 months
  • use of oral corticosteroids
  • use of certain drugs
  • poor adherence to asthma treatment
  • pregnancy
  • psychological or socioeconomic problems
  • elevated blood eosinophils
  • elevated fractional exhaled nitric oxide (FeNO)
  • weather-related triggers
  • respiratory bacterial infection
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • oxygen saturation
  • peak expiratory flow
Todos los datos

Pruebas diagnósticas que deben considerarse

  • ABG
  • chest x-ray
  • CBC
  • metabolic panel for electrolytes, BUN levels, creatinine
Todos los datos

Algoritmo de tratamiento

Agudo

life-threatening exacerbation or impending respiratory failure

severe exacerbation

moderate exacerbation

mild exacerbation

En curso

symptomatic asthma

Colaboradores

Consejeros especializados

Sourav Majumdar, MD

Clinical Assistant Professor (Affiliated)

Division of Pulmonary, Allergy and Critical Care Medicine

Department of Medicine

Stanford University School of Medicine

Stanford, CA

Divulgaciones

SM declares that he has no competing interests.

Lauren Eggert, MD

Clinical Assistant Professor

Division of Pulmonary, Allergy and Critical Care Medicine

Department of Medicine

Stanford University School of Medicine

Stanford, CA

Divulgaciones

LE declares that she has participated on advisory boards for Regeneron, AstraZeneca, and GSK and has received speaking fees from Sanofi and GSK.

Agradecimientos

Dr Sourav Majumdar and Dr Lauren Eggert would like to gratefully acknowledge Dr Ware Kuschner, Dr Michael Ezzie, and Dr Jonathan P. Parsons, the previous contributors to this topic.

Divulgaciones

WK and ME declare that they have no competing interests. JPP is a member of Speakers' Bureaus for GlaxoSmithKline, Schering-Plough, and AstraZeneca.

Revisores por pares

Anne Dixon, MD

Assistant Professor

Pulmonary and Critical Care Medicine

University of Vermont

Burlington, VT

Divulgaciones

AD declares that she has no competing interests.

Neil C. Thomson, MBChB, MD, FRCP

Professor of Respiratory Medicine

Institute of Infection, Immunity & Inflammation

University of Glasgow

Glasgow

Scotland

UK

Divulgaciones

NCT declares that he has no competing interests.

Graeme P. Currie, MBChB, MD, FRCP

Consultant Chest Physician

Chest Clinic C

Aberdeen Royal Infirmary

Aberdeen

Scotland

UK

Divulgaciones

GPC declares that he has no competing interests.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Global Initiative for Asthma. Global strategy for asthma management and prevention. May 2026 [internet publication].Texto completo

Cloutier MM, Baptist AP, Teach SJ, et al; Expert Panel Working Group of the National Heart, Lung, and Blood Institute (NHLBI) administered and coordinated National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC). 2020 focused updates to the asthma management guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. J Allergy Clin Immunol. 2020 Dec;146(6):1217-70.Texto completo  Resumen

British Thoracic Society; Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Nov 2024 [internet publication].Texto completo

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Diferenciales

    • Pneumonia
    • Foreign body/obstruction
    • Vocal cord dysfunction
    Más Diferenciales
  • Guías de práctica clínica

    • Global strategy for asthma management and prevention​
    • 2020 focused updates to the asthma management guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group
    Más Guías de práctica clínica
  • Videos

    Peak flow measurement: animated demonstration

    Expiratory wheeze

    Más vídeos
  • Folletos para el paciente

    Asthma in adults: what are the treament options?

    Asthma in adults: what is it?

    Más Folletos para el paciente
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad